448
Views
81
CrossRef citations to date
0
Altmetric
Review

Cross-protective immunity to influenza A viruses

&
Pages 1325-1341 | Published online: 09 Jan 2014

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (4)

Irina Isakova-Sivak, Elena Grigorieva & Larisa Rudenko. (2020) Insights into current clinical research on the immunogenicity of live attenuated influenza vaccines. Expert Review of Vaccines 19:1, pages 43-55.
Read now
Adam Kenneth Wheatley & Stephen John Kent. (2015) Prospects for antibody-based universal influenza vaccines in the context of widespread pre-existing immunity. Expert Review of Vaccines 14:9, pages 1227-1239.
Read now
Ralf Wagner & Michael Pfleiderer. (2012) Reproducibility of assays for influenza vaccine immunogenicity determination: progress towards consistency. Expert Review of Vaccines 11:8, pages 881-883.
Read now
Leslie A. Reperant, Thijs Kuiken & Albert D.M.E. Osterhaus. (2012) Influenza viruses. Human Vaccines & Immunotherapeutics 8:1, pages 7-16.
Read now

Articles from other publishers (77)

Chaiwat Wilasang, Pikkanet Suttirat, Sudarat Chadsuthi, Anuwat Wiratsudakul & Charin Modchang. (2022) Competitive evolution of H1N1 and H3N2 influenza viruses in the United States: A mathematical modeling study. Journal of Theoretical Biology 555, pages 111292.
Crossref
V. Patil, J. F. Hernandez-Franco, G. Yadagiri, D. Bugybayeva, S. Dolatyabi, N. Feliciano-Ruiz, J. Schrock, J. Hanson, J. Ngunjiri, H. HogenEsch & G. J. Renukaradhya. (2022) A split influenza vaccine formulated with a combination adjuvant composed of alpha-d-glucan nanoparticles and a STING agonist elicits cross-protective immunity in pigs. Journal of Nanobiotechnology 20:1.
Crossref
Andries D. Hulst, Piter Bijma & Mart C. M. De Jong. (2022) Can breeders prevent pathogen adaptation when selecting for increased resistance to infectious diseases?. Genetics Selection Evolution 54:1.
Crossref
Yongbo Qiao, YaXin Zhang, Jie Chen, Shenghui Jin & Yaming Shan. (2022) A biepitope, adjuvant-free, self-assembled influenza nanovaccine provides cross-protection against H3N2 and H1N1 viruses in mice. Nano Research 15:9, pages 8304-8314.
Crossref
Vasilis C. Pliasas, Zach Menne, Virginia Aida, Ji-Hang Yin, Maria C. Naskou, Peter J. Neasham, J. Fletcher North, Dylan Wilson, Katharine A. Horzmann, Joshy Jacob, Ioanna Skountzou & Constantinos S. Kyriakis. (2022) A Novel Neuraminidase Virus-Like Particle Vaccine Offers Protection Against Heterologous H3N2 Influenza Virus Infection in the Porcine Model. Frontiers in Immunology 13.
Crossref
Lorenzo Gatti, Mischa H. Koenen, Jitao David Zhang, Maria Anisimova, Lilly M. Verhagen, Martin Schutten, Ab Osterhaus & Erhard van der Vries. (2022) Cross-reactive immunity potentially drives global oscillation and opposed alternation patterns of seasonal influenza A viruses. Scientific Reports 12:1.
Crossref
David V. McLeod & Sylvain Gandon. (2022) Effects of epistasis and recombination between vaccine-escape and virulence alleles on the dynamics of pathogen adaptation. Nature Ecology & Evolution 6:6, pages 786-793.
Crossref
Mei Peng Tan, Wen Siang Tan, Noorjahan Banu Mohamed Alitheen & Wei Boon Yap. (2021) M2e-Based Influenza Vaccines with Nucleoprotein: A Review. Vaccines 9:7, pages 739.
Crossref
Chia-Yun Lo, Julia A. Misplon, Xing Li, Graeme E. Price, Zhiping Ye & Suzanne L Epstein. (2021) Universal influenza vaccine based on conserved antigens provides long-term durability of immune responses and durable broad protection against diverse challenge virus strains in mice. Vaccine 39:33, pages 4628-4640.
Crossref
Andrew Tung Yep, Yasu Takeuchi, Othmar G. Engelhardt & Simon E. Hufton. (2021) Broad Reactivity Single Domain Antibodies against Influenza Virus and Their Applications to Vaccine Potency Testing and Immunotherapy. Biomolecules 11:3, pages 407.
Crossref
Blake J. M. Williams, Guillaume St-Onge & Laurent Hébert-Dufresne. (2021) Localization, epidemic transitions, and unpredictability of multistrain epidemics with an underlying genotype network. PLOS Computational Biology 17:2, pages e1008606.
Crossref
Veerupaxagouda Patil, Sankar Renu, Ninoshkaly Feliciano-Ruiz, Yi Han, Anikethana Ramesh, Jennifer Schrock, Santosh Dhakal, Harm HogenEsch & Gourapura J. Renukaradhya. (2020) Intranasal Delivery of Inactivated Influenza Virus and Poly(I:C) Adsorbed Corn-Based Nanoparticle Vaccine Elicited Robust Antigen-Specific Cell-Mediated Immune Responses in Maternal Antibody Positive Nursery Pigs. Frontiers in Immunology 11.
Crossref
Chloe H. Lee, Mariana Pereira Pinho, Paul R. Buckley, Isaac B. Woodhouse, Graham Ogg, Alison Simmons, Giorgio Napolitani & Hashem Koohy. (2020) Potential CD8+ T Cell Cross-Reactivity Against SARS-CoV-2 Conferred by Other Coronavirus Strains. Frontiers in Immunology 11.
Crossref
Bernard A.P. LafontJack R. Bennink. (2020) Slowing Influenza Virus Evolution: A Role for Multiple Synergistic Antiviral Specificities in Vaccination Strategies. Viral Immunology 33:3, pages 197-200.
Crossref
N. Arinaminpathy, S. Riley, W. S. Barclay, C. Saad-Roy & B. Grenfell. (2020) Population implications of the deployment of novel universal vaccines against epidemic and pandemic influenza. Journal of The Royal Society Interface 17:164, pages 20190879.
Crossref
Barbara Holzer, Sophie B. Morgan, Veronica Martini, Rajni Sharma, Becky Clark, Christopher Chiu, Francisco J. Salguero & Elma Tchilian. (2019) Immunogenicity and Protective Efficacy of Seasonal Human Live Attenuated Cold-Adapted Influenza Virus Vaccine in Pigs. Frontiers in Immunology 10.
Crossref
Shahinul Islam, Fan Zhou, Sarah Lartey, Kristin G. I. Mohn, Florian Krammer, Rebecca Jane Cox & Karl Albert Brokstad. (2019) Functional immune response to influenza H1N1 in children and adults after live attenuated influenza virus vaccination. Scandinavian Journal of Immunology 90:4.
Crossref
Janelle Rowell, Chia-Yun Lo, Graeme E. Price, Julia A. Misplon, Roberta L. Crim, Priyanka Jayanti, Judy Beeler & Suzanne L. Epstein. (2019) The effect of respiratory viruses on immunogenicity and protection induced by a candidate universal influenza vaccine in mice. PLOS ONE 14:4, pages e0215321.
Crossref
Timothy J. PowellPramila Rijal, Rosanna M. McEwen-Smith, Haewon Byun, Marc Hardwick, Lisa M. Schimanski, Kuan-Ying A. Huang, Rodney S. Daniels & Alain R. M. Townsend. (2019) A single cycle influenza virus coated in H7 haemagglutinin generates neutralizing antibody responses to haemagglutinin and neuraminidase glycoproteins and protection from heterotypic challenge. Journal of General Virology 100:3, pages 431-445.
Crossref
Barbara Holzer, Veronica Martini, Matthew Edmans & Elma Tchilian. (2019) T and B Cell Immune Responses to Influenza Viruses in Pigs. Frontiers in Immunology 10.
Crossref
Judith Del Campo, Andres Pizzorno, Sophia Djebali, Julien Bouley, Marjorie Haller, Jimena Pérez-Vargas, Bruno Lina, Guy Boivin, Marie-Eve Hamelin, Florence Nicolas, Alexandre Le Vert, Yann Leverrier, Manuel Rosa-Calatrava, Jacqueline Marvel & Fergal Hill. (2019) OVX836 a recombinant nucleoprotein vaccine inducing cellular responses and protective efficacy against multiple influenza A subtypes. npj Vaccines 4:1.
Crossref
Ivan Sanz, Silvia Rojo, Sonia Tamames, Jose María Eiros & Raúl Ortiz de Lejarazu. (2018) Antibodies against 1940s era a/H1N1 influenza strains a/Weiss/43 and a/FM/1/47 and heterotypic responses after seasonal vaccination of an elderly Spanish population. Immunity & Ageing 15:1.
Crossref
Suzanne L Epstein. (2018) Universal Influenza Vaccines: Progress in Achieving Broad Cross-Protection In Vivo. American Journal of Epidemiology 187:12, pages 2603-2614.
Crossref
Svetlana Shcherbik, Paul Carney, Nicholas Pearce, James Stevens, Vivien G. Dugan, David E. Wentworth & Tatiana Bousse. (2018) Monoclonal antibody against N2 neuraminidase of cold adapted A/Leningrad/134/17/57 (H2N2) enables efficient generation of live attenuated influenza vaccines. Virology 522, pages 65-72.
Crossref
Graeme E. Price, Chia-Yun Lo, Julia A. Misplon & Suzanne L. Epstein. (2018) Reduction of influenza virus transmission from mice immunized against conserved viral antigens is influenced by route of immunization and choice of vaccine antigen. Vaccine 36:32, pages 4910-4918.
Crossref
Janelle Rowell, Chia-Yun Lo, Graeme E. Price, Julia A. Misplon, Suzanne L. Epstein & Mayra Garcia. (2018) Conventional influenza vaccines influence the performance of a universal influenza vaccine in mice. Vaccine 36:7, pages 1008-1015.
Crossref
Andres H. Gutiérrez, Vicki J. Rapp-Gabrielson, Frances E. Terry, Crystal L. Loving, Leonard Moise, William D. Martin & Anne S. De Groot. (2017) T-cell epitope content comparison (EpiCC) of swine H1 influenza A virus hemagglutinin. Influenza and Other Respiratory Viruses 11:6, pages 531-542.
Crossref
Ivan Sanz, Silvia Rojo, Sonia Tamames, José Eiros & Raúl Ortiz de Lejarazu. (2017) Heterologous Humoral Response against H5N1, H7N3, and H9N2 Avian Influenza Viruses after Seasonal Vaccination in a European Elderly Population. Vaccines 5:3, pages 17.
Crossref
Elma Tchilian & Barbara Holzer. (2017) Harnessing Local Immunity for an Effective Universal Swine Influenza Vaccine. Viruses 9:5, pages 98.
Crossref
Chia-Yun Lo, Susan L. Strobl, Kimberly Dunham, Wei Wang, Lucy Stewart, Julia A. Misplon, Mayra Garcia, Jin Gao, Tatsuhiko Ozawa, Graeme E. Price, Jose Navidad, Steve Gradus, Sanjib Bhattacharyya, Cecile Viboud, Maryna C. Eichelberger, Carol D. Weiss, Jack Gorski & Suzanne L. Epstein. (2017) Surveillance Study of Influenza Occurrence and Immunity in a Wisconsin Cohort During the 2009 Pandemic. Open Forum Infectious Diseases 4:2.
Crossref
Bram SlütterNatalija Van Braeckel-BudimirGeorges AbboudSteven M. VargaShahram Salek-ArdakaniJohn T. Harty. (2017) Dynamics of influenza-induced lung-resident memory T cells underlie waning heterosubtypic immunity. Science Immunology 2:7.
Crossref
Rahul Subramanian, Andrea L. Graham, Bryan T. Grenfell & Nimalan Arinaminpathy. (2016) Universal or Specific? A Modeling-Based Comparison of Broad-Spectrum Influenza Vaccines against Conventional, Strain-Matched Vaccines. PLOS Computational Biology 12:12, pages e1005204.
Crossref
Sophie B. Morgan, Johanneke D. Hemmink, Emily Porter, Ross Harley, Holly Shelton, Mario Aramouni, Helen E. Everett, Sharon M. Brookes, Michael Bailey, Alain M. Townsend, Bryan Charleston & Elma Tchilian. (2016) Aerosol Delivery of a Candidate Universal Influenza Vaccine Reduces Viral Load in Pigs Challenged with Pandemic H1N1 Virus. The Journal of Immunology 196:12, pages 5014-5023.
Crossref
Mayra García, Julia A. Misplon, Graeme E. Price, Chia-Yun Lo & Suzanne L. Epstein. (2016) Age Dependence of Immunity Induced by a Candidate Universal Influenza Vaccine in Mice. PLOS ONE 11:4, pages e0153195.
Crossref
Weiguang Zeng, Kylie J. Horrocks, Amabel C. L. Tan & David C. Jackson. (2016) Chemical Synthesis of Monomeric, Dimeric and Tetrameric Forms of the Ectodomain of Influenza Matrix 2 Protein. European Journal of Organic Chemistry 2016:5, pages 1054-1059.
Crossref
Svetlana Shcherbik, Nicholas Pearce, Irina Kiseleva, Natalie Larionova, Larisa Rudenko, Xiyan Xu, David E. Wentworth & Tatiana Bousse. (2016) Implementation of new approaches for generating conventional reassortants for live attenuated influenza vaccine based on Russian master donor viruses. Journal of Virological Methods 227, pages 33-39.
Crossref
Xu-Sheng Zhang. (2015) Strain Interactions as a Mechanism for Dominant Strain Alternation and Incidence Oscillation in Infectious Diseases: Seasonal Influenza as a Case Study. PLOS ONE 10:11, pages e0142170.
Crossref
A B Rodriguez-Peña, J Gomez-Rodriguez, R L Kortum, D C Palmer, Z Yu, G C Guittard, E A Wohlfert, P B Silver, J A Misplon, C L Sommers, L Feigenbaum, S L Epstein, R R Caspi, Y Belkaid, N P Restifo, L E Samelson & L Balagopalan. (2015) Enhanced T-cell activation and differentiation in lymphocytes from transgenic mice expressing ubiquitination-resistant 2KR LAT molecules. Gene Therapy 22:10, pages 781-792.
Crossref
Ana F. Rodrigues, Hugo R. Soares, Miguel R. Guerreiro, Paula M. Alves & Ana S. Coroadinha. (2015) Viral vaccines and their manufacturing cell substrates: New trends and designs in modern vaccinology. Biotechnology Journal 10:9, pages 1329-1344.
Crossref
Hiroko Matsumoto, Satoko Ohfuji, Kenji Watanabe, Hirokazu Yamagami, Wakaba Fukushima, Kazuhiro Maeda, Noriko Kamata, Mitsue Sogawa, Masatsugu Shiba, Tetsuya Tanigawa, Kazunari Tominaga, Toshio Watanabe, Yasuhiro Fujiwara, Yoshio Hirota & Tetsuo Arakawa. (2015) Booster influenza vaccination does not improve immune response in adult inflammatory bowel disease patients treated with immunosuppressives: a randomized controlled trial. Journal of Gastroenterology 50:8, pages 876-886.
Crossref
Weiguang Zeng, Amabel C.L. Tan, Kylie Horrocks & David C. Jackson. (2015) A lipidated form of the extracellular domain of influenza M2 protein as a self-adjuvanting vaccine candidate. Vaccine 33:30, pages 3526-3532.
Crossref
Viroj WiwanitkitHuan Huu Nguyen & De-chu Christopher Tang. 2015. Current Issues with Influenza Management. Current Issues with Influenza Management 130 146 .
Andrew J. Broadbent, Kobporn Boonnak & Kanta Subbarao. 2015. Mucosal Immunology. Mucosal Immunology 1129 1170 .
K. Bednarska, M. A. Nowak, K. Kondratiuk, E. Hallmann-Szelińska & L. B. Brydak. 2015. Pulmonary Infection. Pulmonary Infection 45 50 .
Xu-Sheng Zhang, Richard Pebody, Daniela De Angelis, Peter J. White, Andre Charlett & John W. McCauley. (2014) The Possible Impact of Vaccination for Seasonal Influenza on Emergence of Pandemic Influenza via Reassortment. PLoS ONE 9:12, pages e114637.
Crossref
Daniel J Puleston, Hanlin Zhang, Timothy J Powell, Elina Lipina, Stuart Sims, Isabel Panse, Alexander S Watson, Vincenzo Cerundolo, Alain RM Townsend, Paul Klenerman & Anna Katharina Simon. (2014) Autophagy is a critical regulator of memory CD8+ T cell formation. eLife 3.
Crossref
Brian J. Laidlaw, Nianzhi Zhang, Heather D. Marshall, Mathew M. Staron, Tianxia Guan, Yinghong Hu, Linda S. Cauley, Joe Craft & Susan M. Kaech. (2014) CD4+ T Cell Help Guides Formation of CD103+ Lung-Resident Memory CD8+ T Cells during Influenza Viral Infection. Immunity 41:4, pages 633-645.
Crossref
Ralph Tripp & S. Tompkins. (2014) Virus-Vectored Influenza Virus Vaccines. Viruses 6:8, pages 3055-3079.
Crossref
Graeme E. Price, Chia-Yun Lo, Julia A. Misplon & Suzanne L. Epstein. (2014) Mucosal Immunization with a Candidate Universal Influenza Vaccine Reduces Virus Transmission in a Mouse Model. Journal of Virology 88:11, pages 6019-6030.
Crossref
S. L. Epstein & M. Garcia. (2013) Survey of Human Antibody Responses to Influenza Virus Matrix Protein 2 by Use of a Sensitive Flow Cytometric Method. Journal of Infectious Diseases 209:7, pages 975-977.
Crossref
Masanori Terajima, Jenny Aurielle B Babon, Mary Dawn T Co & Francis A Ennis. (2013) Cross-reactive human B cell and T cell epitopes between influenza A and B viruses. Virology Journal 10:1.
Crossref
Emily A. Hemann, Sang-Moo Kang & Kevin L. Legge. (2013) Protective CD8 T Cell–Mediated Immunity against Influenza A Virus Infection following Influenza Virus–like Particle Vaccination. The Journal of Immunology 191:5, pages 2486-2494.
Crossref
S. Yan & G. Wu. (2013) Small Variations Between Species/Subtypes Attributed to Reassortment Evidenced from Polymerase Basic Protein 1 with Other Seven Proteins from Influenza A Virus. Transboundary and Emerging Diseases 60:2, pages 110-119.
Crossref
Brian J. Laidlaw, Vilma Decman, Mohammed-Alkhatim A. Ali, Michael C. Abt, Amaya I. Wolf, Laurel A. Monticelli, Krystyna Mozdzanowska, Jill M. Angelosanto, David Artis, Jan Erikson & E. John Wherry. (2013) Cooperativity Between CD8+ T Cells, Non-Neutralizing Antibodies, and Alveolar Macrophages Is Important for Heterosubtypic Influenza Virus Immunity. PLoS Pathogens 9:3, pages e1003207.
Crossref
Teresa Lambe, John B. Carey, Yuanyuan Li, Alexandra J. Spencer, Arjan van Laarhoven, Caitlin E. Mullarkey, Anto Vrdoljak, Anne C. Moore & Sarah C. Gilbert. (2013) Immunity Against Heterosubtypic Influenza Virus Induced By Adenovirus And MVA Expressing Nucleoprotein And Matrix Protein-1. Scientific Reports 3:1.
Crossref
Alessandra Vitelli, Mary R. Quirion, Chia-Yun Lo, Julia A. Misplon, Agnieszka K. Grabowska, Angiolo Pierantoni, Virginia Ammendola, Graeme E. Price, Mark R. Soboleski, Riccardo Cortese, Stefano Colloca, Alfredo Nicosia & Suzanne L. Epstein. (2013) Vaccination to Conserved Influenza Antigens in Mice Using a Novel Simian Adenovirus Vector, PanAd3, Derived from the Bonobo Pan paniscus. PLoS ONE 8:3, pages e55435.
Crossref
Yo Han Jang, Young Ho Byun, Dong-Hun Lee, Kwang-Hee Lee, Yoon Jae Lee, Yun Ha Lee, Jae-Keun Park, Chang-Seon Song & Baik Lin Seong. (2013) Cold-adapted X-31 live attenuated 2009 pandemic H1N1 influenza vaccine elicits protective immune responses in mice and ferrets. Vaccine 31:9, pages 1320-1327.
Crossref
Dimitrios G. Koutsonanos, Richard W. Compans & Ioanna Skountzou. 2013. Crossroads Between Innate and Adaptive Immunity IV. Crossroads Between Innate and Adaptive Immunity IV 121 132 .
Timothy J. Powell, Jonathan D. Silk, Jane Sharps, Ervin Fodor & Alain R. M. Townsend. (2012) Pseudotyped Influenza A Virus as a Vaccine for the Induction of Heterotypic Immunity. Journal of Virology 86:24, pages 13397-13406.
Crossref
Katherine A. Richards, Francisco A. Chaves, Shabnam Alam & Andrea J. Sant. (2012) Trivalent inactivated influenza vaccines induce broad immunological reactivity to both internal virion components and influenza surface proteins. Vaccine 31:1, pages 219-225.
Crossref
Rogier Bodewes, Pieter L.A. Fraaij, Joost H.C.M. Kreijtz, Martina M. Geelhoed-Mieras, Ron A.M. Fouchier, Albert D.M.E. Osterhaus & Guus F. Rimmelzwaan. (2012) Annual influenza vaccination affects the development of heterosubtypic immunity. Vaccine 30:51, pages 7407-7410.
Crossref
Laura Haynes, Frank M. Szaba, Sheri M. Eaton, Lawrence W. Kummer, Paula A. Lanthier, Ashlee H. Petell, Debra K. Duso, Deyan Luo, Jr-Shiuan Lin, Julie S. Lefebvre, Troy D. Randall, Lawrence L. Johnson, Jacob E. Kohlmeier, David L. Woodland & Stephen T. Smiley. (2012) Immunity to the Conserved Influenza Nucleoprotein Reduces Susceptibility to Secondary Bacterial Infections. The Journal of Immunology 189:10, pages 4921-4929.
Crossref
Jianfeng Zhang. (2012) Advances and Future Challenges in Recombinant Adenoviral Vectored H5N1 Influenza Vaccines. Viruses 4:11, pages 2711-2735.
Crossref
Teresa Lambe. (2012) Novel Viral Vectored Vaccines for the Prevention of Influenza. Molecular Medicine 18:8, pages 1153-1160.
Crossref
K. Kai McKinstry, Tara M. Strutt, Yi Kuang, Deborah M. Brown, Stewert Sell, Richard W. Dutton & Susan L. Swain. (2012) Memory CD4+ T cells protect against influenza through multiple synergizing mechanisms. Journal of Clinical Investigation 122:8, pages 2847-2856.
Crossref
M. Koopmans, E. de Bruin, G.-J. Godeke, I. Friesema, R. van Gageldonk, M. Schipper, A. Meijer, R. van Binnendijk, G.F. Rimmelzwaan, M. D. de Jong, A. Buisman, J. van Beek, D. van de Vijver & J. Reimerink. (2012) Profiling of humoral immune responses to influenza viruses by using protein microarray. Clinical Microbiology and Infection 18:8, pages 797-807.
Crossref
Hirokazu Hikono, Ayako Miyazaki, Masaji Mase, Makoto Inoue, Mamoru Hasegawa & Takehiko Saito. (2012) Induction of a cross-reactive antibody response to influenza virus M2 antigen in pigs by using a Sendai virus vector. Veterinary Immunology and Immunopathology 146:1, pages 92-96.
Crossref
Nimalan ArinaminpathyOliver RatmannKatia Koelle, Suzanne L. Epstein, Graeme E. Price, Cecile Viboud, Mark A. Miller & Bryan T. Grenfell. (2012) Impact of cross-protective vaccines on epidemiological and evolutionary dynamics of influenza. Proceedings of the National Academy of Sciences 109:8, pages 3173-3177.
Crossref
Anne Kelso. (2012) CD4+ T cells limit the damage in influenza. Nature Medicine 18:2, pages 200-202.
Crossref
Garry W Lynch, Paul Selleck, W Bret Church & John S Sullivan. (2011) Seasoned adaptive antibody immunity for highly pathogenic pandemic influenza in humans. Immunology & Cell Biology 90:2, pages 149-158.
Crossref
Rogier Bodewes, Pieter L. A. Fraaij, Martina M. Geelhoed-Mieras, Carel A. van Baalen, Harm A. W. M. Tiddens, Annemarie M. C. van Rossum, Fiona R. van der Klis, Ron A. M. Fouchier, Albert D. M. E. Osterhaus & Guus F. Rimmelzwaan. (2011) Annual Vaccination against Influenza Virus Hampers Development of Virus-Specific CD8 + T Cell Immunity in Children . Journal of Virology 85:22, pages 11995-12000.
Crossref
Paula A. Lanthier, Gail E. Huston, Amy Moquin, Sheri M. Eaton, Frank M. Szaba, Lawrence W. Kummer, Micheal P. Tighe, Jacob E. Kohlmeier, Patrick J. Blair, Michael Broderick, Stephen T. Smiley & Laura Haynes. (2011) Live attenuated influenza vaccine (LAIV) impacts innate and adaptive immune responses. Vaccine 29:44, pages 7849-7856.
Crossref
Nicasio Mancini, Laura Solforosi, Nicola Clementi, Donata De Marco, Massimo Clementi & Roberto Burioni. (2011) A potential role for monoclonal antibodies in prophylactic and therapeutic treatment of influenza. Antiviral Research 92:1, pages 15-26.
Crossref
Jonathan W Yewdell. (2011) Viva la revolución: rethinking influenza A virus antigenic drift. Current Opinion in Virology 1:3, pages 177-183.
Crossref
Peter Pushko, Melissa B. Pearce, Attiya Ahmad, Irina Tretyakova, Gale Smith, Jessica A. Belser & Terrence M. Tumpey. (2011) Influenza virus-like particle can accommodate multiple subtypes of hemagglutinin and protect from multiple influenza types and subtypes. Vaccine 29:35, pages 5911-5918.
Crossref
Mark R. Soboleski, Jon D. Gabbard, Graeme E. Price, Julia A. Misplon, Chia-Yun Lo, Daniel R. Perez, Jianqiang Ye, S. Mark Tompkins & Suzanne L. Epstein. (2011) Cold-Adapted Influenza and Recombinant Adenovirus Vaccines Induce Cross-Protective Immunity against pH1N1 Challenge in Mice. PLoS ONE 6:7, pages e21937.
Crossref
Marine L. B. Hillaire, Albert D. M. E. Osterhaus & Guus F. Rimmelzwaan. (2011) Induction of Virus-Specific Cytotoxic T Lymphocytes as a Basis for the Development of Broadly Protective Influenza Vaccines. Journal of Biomedicine and Biotechnology 2011, pages 1-12.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.